GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Sells $5,459,510.70 in Stock


GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total value of $5,459,510.70. Following the sale, the chief executive officer now owns 63,348 shares in the company, valued at $5,165,395.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Jan Makela also recently made the following trade(s):

  • On Monday, May 13th, Jan Makela sold 20,227 shares of GE HealthCare Technologies stock. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39.

GE HealthCare Technologies Stock Down 0.7 %

Shares of NASDAQ GEHC opened at $81.31 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The firm has a market capitalization of $37.11 billion, a price-to-earnings ratio of 23.77, a PEG ratio of 2.91 and a beta of 1.26. The stock has a 50 day moving average price of $86.31 and a 200 day moving average price of $79.95. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, hitting the consensus estimate of $0.90. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.85 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date was Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.51%.

Institutional Investors Weigh In On GE HealthCare Technologies

Several large investors have recently modified their holdings of GEHC. Capital Research Global Investors increased its holdings in GE HealthCare Technologies by 5.2% during the first quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after buying an additional 2,647,204 shares during the period. Vanguard Group Inc. boosted its position in GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after acquiring an additional 4,107,746 shares in the last quarter. Hotchkis & Wiley Capital Management LLC increased its holdings in shares of GE HealthCare Technologies by 9.4% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock valued at $426,186,000 after acquiring an additional 471,910 shares during the period. Invesco Ltd. raised its position in shares of GE HealthCare Technologies by 21.4% in the 3rd quarter. Invesco Ltd. now owns 5,048,262 shares of the company’s stock worth $343,484,000 after acquiring an additional 889,297 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in shares of GE HealthCare Technologies by 8.9% during the 3rd quarter. Northern Trust Corp now owns 4,205,506 shares of the company’s stock worth $286,143,000 after purchasing an additional 342,040 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. HSBC initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target for the company. Mizuho reduced their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Argus boosted their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price target for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.80.

Read Our Latest Analysis on GEHC

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also



Receive News & Ratings for GE HealthCare Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for GE HealthCare Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.

link

Leave a Reply

Your email address will not be published. Required fields are marked *